コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 thelial cells, and neural cells derived from human embryonic stem cells.
2 ith the undifferentiated status of mouse and human embryonic stem cells.
3 nct developmental identities of mouse versus human embryonic stem cells.
4 cts transcriptional silencing of INK4-ARF in human embryonic stem cells.
5 the appropriate telomere length set point in human embryonic stem cells.
6 chromatin hallmarks of a bivalent domain in human embryonic stem cells.
7 rly human pre-implantation embryos and naive human embryonic stem cells.
8 n mesendodermal differentiation of mouse and human embryonic stem cells.
9 by mapping the m(6)A methylome in mouse and human embryonic stem cells.
10 ces to directed, in vitro differentiation of human embryonic stem cells.
11 ency by repressing let-7 miRNA expression in human embryonic stem cells.
12 ring pancreatic endocrine differentiation of human embryonic stem cells.
13 e regeneration in place of the controversial human embryonic stem cells.
14 ctivities during in vitro differentiation of human embryonic stem cells.
15 applied it to analyze a ChIP-seq dataset in human embryonic stem cells.
16 adeno-associated virus integration site 1 in human embryonic stem cells.
17 Similar results were obtained in human embryonic stem cells.
18 rdiac mesoderm formation in frog embryos and human embryonic stem cells.
19 e developmental and pluripotent potential of human embryonic stem cells.
20 olyamides to genomes directly within live H1 human embryonic stem cells.
21 es bound by Polycomb repressive complex 2 in human embryonic stem cells.
22 rom the ethical issues or immune barriers of human embryonic stem cells.
23 ntial for actinomycin-D-induced apoptosis in human embryonic stem cells.
24 n glycosphingolipids previously described in human embryonic stem cells, a number of type 2 core chai
26 logy development, applications of IDP-ASE to human embryonic stem cells and breast cancer cells indic
31 uripotent stem cells (hPSCs), including both human embryonic stem cells and human-induced pluripotent
32 authors show that ablation of PRC2 genes in human embryonic stem cells and in mice results in change
33 eded to maintain stem cell cultures, so that human embryonic stem cells and induced pluripotent stem
34 an pluripotent stem cells (hPSCs), including human embryonic stem cells and induced pluripotent stem
36 robust EHTs from cardiomyocytes derived from human embryonic stem cells and induced pluripotent stem
37 poietic emergence from hPSCs, including both human embryonic stem cells and inducible pluripotent ste
38 We defined a Smad2 regulatory circuit in human embryonic stem cells and mouse epiblast stem cells
42 2015) derive oligodendrocyte precursors from human embryonic stem cells and show that engrafted cells
43 ANOG, at levels similar to those measured in human embryonic stem cells and to acquire a plastic stat
44 ssion of a single copy of the mutant SOD1 in human embryonic stem cells and were prevented by genetic
45 d it to interrogate the 2-Mb POU5F1 locus in human embryonic stem cells, and identified 45 cis-regula
47 describe a micropatterning approach in which human embryonic stem cells are confined to disk-shaped,
48 mplex 2 is dispensable for pluripotency when human embryonic stem cells are converted into the naive
49 mark at the promoter regions in pluripotent human embryonic stem cells, are essentially devoid of DN
51 OCT4-targeting guide RNA using an inducible human embryonic stem cell-based system and microinjectio
52 capability, there are great expectations for human embryonic stem cells, both as a resource for funct
53 definitive endoderm (DE) differentiation of human embryonic stem cells by attenuating the duration o
54 In this issue, Chung et al. (2014) generate human embryonic stem cells by fusing an adult somatic ce
57 et al. (2016) show that a confined colony of human embryonic stem cells can spontaneously sense its b
58 ut of polycomb repressive complex 2 genes in human embryonic stem cells causes pluripotency loss and
60 d a system using neurons differentiated from human embryonic stem cells, cultured in microfluidic dev
61 f EZH2 in embryonic pancreas explants and in human embryonic stem cell cultures increased endocrine p
62 implantation blastocysts, and ceasing during human embryonic stem cell derivation from blastocyst out
64 e molecular signatures in 1-year (y) matured human embryonic stem cell-derived cardiomyocytes (hESC-C
70 cts, consistent with patch-clamp studies, on human embryonic stem cell-derived cardiomyocytes hESC-CM
71 art muscles (EHMs) were generated by casting human embryonic stem cell-derived cardiomyocytes with co
72 IKV infection leads to microcephaly, we used human embryonic stem cell-derived cerebral organoids to
73 selective for NSCs than mature neurons in a human embryonic stem cell-derived culture containing a m
74 enerated mouse monoclonal antibodies against human embryonic stem cell-derived definitive endoderm wi
79 uring TGF-beta-induced SM differentiation of human embryonic stem cell-derived mesenchymal cells.
80 yonic neural progenitor cells in vivo and on human embryonic stem cell-derived neural progenitors.
81 pecifically activated following infection of human embryonic stem cell-derived neurons and that this
83 of 1776 cells by scRNA-seq covering distinct human embryonic stem cell-derived progenitor states.
84 modified mRNA transfection can be applied to human embryonic stem cell-derived RPE cells and that the
85 We therefore evaluated TVM expression in a human embryonic stem cell-derived teratoma (hESCT) tumor
88 y pathways block the rejection of xenogeneic human embryonic-stem-cell-derived pancreatic endoderm (h
89 e the transcriptome of distal projections of human embryonic stem cells differentiated using a protoc
90 ets and identify key kinases associated with human embryonic stem cell differentiation and insulin si
93 d this strategy to isolate hPSCs (hiPSCs and human embryonic stem cells) during routine culture and s
94 sformed lymphoblastoid cell lines (LCLs) and human embryonic stem cell (ES) lines, but were not signi
97 ood, Rafii et al present an elegant study of human embryonic stem cell (ESC)-derived hematopoiesis in
98 we produced RNA-genome interaction maps for human embryonic stem cells (ESCs) and human embryonic ki
99 ient generation of hypothalamic neurons from human embryonic stem cells (ESCs) and induced pluripoten
100 thylation are not intrinsically different in human embryonic stem cells (ESCs) and induced pluripoten
101 a system for precise genetic modification of human embryonic stem cells (ESCs) and induced pluripoten
102 ntiation of forebrain GABA interneurons from human embryonic stem cells (ESCs) and induced pluripoten
105 inal organoids (HIOs) produced in vitro from human embryonic stem cells (ESCs) or induced pluripotent
106 Whether neurons generated in vitro from human embryonic stem cells (ESCs) or induced pluripotent
107 lly active DNA methyltransferases (DNMTs) in human embryonic stem cells (ESCs) using CRISPR/Cas9 geno
108 ancers identified by chromatin signatures in human embryonic stem cells (ESCs), capture 77% of RNA po
109 We compare nucleosome occupancy in mouse and human embryonic stem cells (ESCs), induced-pluripotent s
112 tegration of human imaging reporter genes in human embryonic stem cells for long-term molecular imagi
113 ted by in vitro neural differentiation of FX human embryonic stem cells (FX-hESCs), derived from FXS
114 mino)ethyl acrylate, which support long-term human embryonic stem cell growth and pluripotency over a
117 regulated in the hemogenic population during human embryonic stem cell hematopoietic differentiation
118 ein-coding genes (exomes) of 140 independent human embryonic stem cell (hES cell) lines, including 26
119 This two-step strategy was used to establish human embryonic stem cell (hESC) and induced pluripotent
120 eeding on CPC for bone regeneration, and (5) human embryonic stem cell (hESC) and induced pluripotent
124 ed splicing (epi)genetic code, DeepCode, for human embryonic stem cell (hESC) differentiation by inte
126 e established several human stem cell lines: human embryonic stem cell (hESC) line carrying the commo
127 ted from a large number (1 x 10(9) cells) of human embryonic stem cell (hESC) lines allowed identific
128 e undertaken a transcriptional comparison of human embryonic stem cell (hESC) lines and hiPSC lines a
134 n chromosome 10) during neurite outgrowth of human embryonic stem cell (hESC)-derived neuronal progen
136 xpression analysis of >30 batches of grafted human embryonic stem cell (hESC)-derived progenitors.
142 ional (3D) neuronal cell models derived from human embryonic stem cells (hESC) provide an excellent t
143 rm to long-term safety of cells derived from human embryonic stem cells (hESC) transplanted into pati
144 in conformations in the nucleoli of iPSC and human embryonic stem cells (hESC) were found to be simil
145 ds used to differentiate and purify RPE from human embryonic stem cells (HESC), and describe the surg
146 rated the monoclonal antibody mAb-A4 against human embryonic stem cells (hESC), which also bound spec
149 her transplanted MGE-like cells derived from human embryonic stem cells (hESC-MGEs) can mitigate the
150 l models of SDS through knockdown of SBDS in human embryonic stem cells (hESCs) and generation of ind
153 fficient generation of striatal neurons from human embryonic stem cells (hESCs) and induced pluripote
154 fundamental to the activity and behavior of human embryonic stem cells (hESCs) and induced pluripote
156 how that a sub-population within cultures of human embryonic stem cells (hESCs) and induced pluripote
157 steogenic progenitor cells derived from both human embryonic stem cells (hESCs) and induced pluripote
158 e demonstrated ability to differentiate both human embryonic stem cells (hESCs) and patient-derived i
159 metabolism changes during differentiation of human embryonic stem cells (hESCs) and reprogramming of
166 Under defined differentiation conditions, human embryonic stem cells (hESCs) can be directed towar
170 Furthermore, replication profiles of FXS human embryonic stem cells (hESCs) compared to nonaffect
173 at TET1, TET2 and TET3 triple-knockout (TKO) human embryonic stem cells (hESCs) exhibit prominent biv
175 nts in the human embryo, we used colonies of human embryonic stem cells (hESCs) grown on micropattern
178 tors or insulin-secreting cells derived from human embryonic stem cells (hESCs) has been proposed as
181 induced pluripotent stem cells (hiPSCs) and human embryonic stem cells (hESCs) have the capacity to
183 role of the WNT receptor FZD7 in maintaining human embryonic stem cells (hESCs) in an undifferentiate
184 n interactions and target gene expression in human embryonic stem cells (hESCs) in response to early
185 vo and influence differentiation outcomes in human embryonic stem cells (hESCs) in vitro Systematic i
187 determinants regulating the specification of human embryonic stem cells (hESCs) into hematopoietic ce
188 mics occurring during the differentiation of human embryonic stem cells (HESCs) into the erythroid li
189 in vitro method to direct differentiation of human embryonic stem cells (hESCs) into thymic epithelia
192 Maintenance of the self-renewal state in human embryonic stem cells (hESCs) is the foremost criti
193 ) cells in spin embryoid bodies derived from human embryonic stem cells (hESCs) lack HOXA expression
194 re concurrently overexpressed in transformed human embryonic stem cells (hESCs) or hESCs cultured in
195 colonic organoids (COs) from differentiated human embryonic stem cells (hESCs) or induced pluripoten
198 induced pluripotent stem cells (hiPSCs) and human embryonic stem cells (hESCs) remains controversial
200 ime the properties of neurons developed from human embryonic stem cells (hESCs) that carry the FMR1 m
201 this study we investigated the potential of human embryonic stem cells (hESCs) to differentiate into
204 re, we use both developing mouse embryos and human embryonic stem cells (hESCs) to explore the mechan
205 es in the 26-day directed differentiation of human embryonic stem cells (hESCs) to insulin-positive c
207 anslational modifications and p53 binding in human embryonic stem cells (hESCs) undergoing differenti
209 rofiles that are differentially changed when human embryonic stem cells (hESCs) were differentiated t
211 ly in cells undergoing reprogramming but not human embryonic stem cells (hESCs), and inhibiting TRAIL
213 fferentiation, we quantified the proteome of human embryonic stem cells (hESCs), cardiac progenitor c
214 ed the epigenetic status of undifferentiated human embryonic stem cells (hESCs), hESC-derived early e
216 dynamics during directed differentiation of human embryonic stem cells (hESCs), we identified a supp
217 s are reproduced by expressing mutant FUS in human embryonic stem cells (hESCs), whereas knockdown of
237 in GSL expression during differentiation of human embryonic stem cells; however, little is known abo
238 gize to induce endodermal differentiation of human embryonic stem cells; however, the underlying mech
239 ed to levitate neuroprogenitors derived from human embryonic stem cells in 3D multilayered fibrin tis
240 onserved, as shown by the differentiation of human embryonic stem cells in a model of human pancreas
245 tly reported the in vitro differentiation of human embryonic stem cells into insulin-secreting cells,
247 of embryonic development, we differentiated human embryonic stem cells into mesendoderm, neural prog
248 raftment of cardiac progenitors derived from human embryonic stem cells into patients is now feasible
249 ly controlled gene regulation in 3D-cultured human embryonic stem cells is developed using hollow gol
252 h an EFNB2-tdTomato/EPHB4-EGFP dual reporter human embryonic stem cell line to identify factors that
253 produced by an 80% RUNX1 knockdown in the H9 human embryonic stem cell line, and a genomic instabilit
254 bitor of CARM1-mediated H3R17 methylation in human embryonic stem cell line, we find that H3R17 methy
258 lineage allocation in humans, we derived ten human embryonic stem cell lines (designated UCSFB1-10) f
259 target five genes in three hPSC lines: three human embryonic stem cell lines, neural progenitors and
260 pid, has been commonly used as a pluripotent human embryonic stem cell marker, and its expression is
263 ed protocols for directed differentiation of human embryonic stem cells, obtaining efficient, acceler
264 transplantable insulin-producing cells from human embryonic stem cells or induced pluripotent stem c
265 rogenitor cells (hGPCs), derived from either human embryonic stem cells or mHTT-transduced fetal hGPC
266 onic pathways related to cell proliferation, human embryonic stem cell pluripotency, tissue regenerat
267 ntestinal and metabolic tissues derived from human embryonic stem cells, populated by gut microbiota.
269 sive mature beta cells that are derived from human embryonic stem cells (referred to as SC-beta cells
272 ded to federal funding limitations placed on human embryonic stem cell research and the potential of
273 tion in neural progenitor cells derived from human embryonic stem cells, resulting in neoplastic tran
274 Now, modern genome-editing techniques in human embryonic stem cells reveal TPP1 as the essential
275 ng pancreatic and hepatic differentiation of human embryonic stem cells revealed the en masse acquisi
277 ll, Wang et al. find that linc-RoR maintains human embryonic stem cell self-renewal by functioning as
279 ructs built with cardiomyocytes derived from human embryonic stem cells, simultaneous optical and ele
282 ngle cells in a population of methanol-fixed human embryonic stem cells, the histogram of corrected 7
283 repressive complex 2 (PRC2) binding sites in human embryonic stem cells, thereby phenocopying a more
284 can be efficiently generated from mouse and human embryonic stem cells through manipulation of the t
285 lling pathways, we develop a method to guide human embryonic stem cells to a near-pure population (>9
287 ional design of differentiation protocols of human embryonic stem cells to specific cell types for di
289 riptional data across the differentiation of human embryonic stem cells to the three germ layers.
290 BAergic interneuron progenitors derived from human embryonic stem cells to treat chronic temporal lob
291 ract enhancer signatures in a representative human embryonic stem cell type (H1) and a differentiated
293 ned expression signatures more comparable to human embryonic stem cell VPs, expressed higher levels o
294 K293T, human primary neonatal fibroblast and human embryonic stem cells was increased dramatically re
300 P-RNAPII (RNA polymerase II) at promoters in human embryonic stem cells, with a minor peak in the ter
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。